The novel coronavirus disease 2019 (COVID-19) pandemic is a public health emergency of international concern, bringing a multitude of new challenges in caring for patients. There is considerable variability in the prevalence of the virus as well as the availability of personal protective equipment (PPE) worldwide.
Ultrasonography examinations involve close, often prolonged (>10 minutes) physical contact with patients and confer a high risk of viral transmission by respiratory droplets. This is particularly the case for ocular ultrasound, with the practitioner positioned directly above the patient’s head in close proximity to the upper respiratory tract and nasopharnyx.1 Furthermore, Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) viral RNA has been detected in ocular swab samples in patients with conjunctivitis and in ocular fluids in the early incubation period before the onset of characteristic respiratory symptoms. Therefore, ocular fluids may not only be the point of virus entry but also a source of contagion to other patients and eye care professionals.2
Strict protective measures by each ultrasonography operator are necessary when performing an examination on patients positive for COVID-19. The American Institute of Ultrasound in Medicine advises that all patients be considered as possibly infected with COVID-19 for the purposes of protecting personnel.3 Radiologic and ophthalmologic societies recommend that all examinations be strictly limited to an absolute minimum. Given the limited supply of PPE, health care professionals are at high risk of contamination, including those in ophthalmology, previously considered a low-risk subspecialty.4
In response to the COVID-19 pandemic, we, as an institution, have devised a high-resolution MR imaging protocol as a substitute for ocular ultrasonography in the setting of ophthalmologic emergencies. This is an initiative by the radiology department in collaboration with our ophthalmology colleagues, as a risk-mitigation strategy to protect staff while maintaining optimum patient care.1 Local institutional review board authorization was granted.
All MR imaging examinations are performed at 3T. Our protocol is centered on the orbits with high-resolution 3D T1-weighted sequences before and after intravenous injection of gadolinium chelate and a 3D T2-weighted sequence. We obtain high in-plane spatial resolution of the order of 0.45–0.55 mm, which is obtainable on most commercially available MR imaging scanners. Practically, this allows reconstructions in any plane approximating the accuracy of B-mode ultrasound at 10 MHz, which can localize anomalies according to standard field or meridian nomenclature.
Urgent or emergent examinations are determined on an individual basis but include those entities requiring immediate clinical or surgical intervention, often with sight-threatening complications, including ocular trauma, retinal detachment, choroidal detachment, vitreous hemorrhage, and ocular tumors. We illustrate the value of ocular MR imaging in some of these settings (Figs 1–3).
In conclusion, we show that ocular MR imaging can be a useful diagnostic tool as a substitute for ultrasound and a temporary measure during the COVID-19 pandemic. The sensitivity and specificity of MR imaging compared with ultrasound for the investigation of ocular emergencies is not currently known; therefore, further studies are required.
Footnotes
Disclosures: Julien Savatovsky—UNRELATED: Consultancy: Bayer AG; Payment for Lectures Including Service on Speakers Bureaus: Philips, Medtronic; Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: Bayer AG.
Indicates open access to non-subscribers at www.ajnr.org
- © 2020 by American Journal of Neuroradiology